Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Clinical trial NCT01057810 · COMPLETED

Trial details

NCT number: NCT01057810
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-07-01
Primary completion: 2015-04-01
Enrollment: 837

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.